EATG, News ViiV Healthcare launches phase III programme to evaluate a long-acting, injectable HIV treatment regimen November 18, 2016 1255
Facebook Twitter Google+ Post Views: 1,255 ARTHIV/AIDSTreatment Share the News Facebook Twitter VKontakte Google+ Fast-track update on investments needed in the AIDS responce. UNAIDS 2016. Reference. European Antibiotic Awareness Day 2016 Related News 1748 Behavioral intervention reduces HIV transmission risk in young transgender women 2240 Global progress towards hepatitis C elimination still blocked by cost of treatment, lack of diagnosis 2141 Vladimir Zhovtyak: European AIDS conference is a step forward to control the HIV/AIDS in Europe 2039 Patient Communities Agree on Shared Vision of HIV Treatment Regimen 2508 Glecaprevir/pibrentasvir is effective for people with HIV/HCV co-infection
2240 Global progress towards hepatitis C elimination still blocked by cost of treatment, lack of diagnosis
ПОИСК ПО САЙТУ 
поиск по ресурсному центру 
